截至9月3日，西部利得港股通新机遇混合A近三个月复权单位净值增长率为15.15%，位于同类可比基金533/880；近半年复权单位净值增长率为15.00%，位 于同类可比基金498/880；近一年复权单位净值增长率为37.43%，位于同类可比基金452/880；近三年复权单位净值增长率为-9.60%，位于同类可比基金 665/872。 AI基金西部利得港股通新机遇混合A（008861）披露2025年中期报告，上半年基金利润289.02万元，加权平均基金份额本期利润0.1元。报告期内，基金净值 增长率为18.93%，截至上半年末，基金规模为1764.93万元。 该基金属于灵活配置型基金。截至9月3日，单位净值为0.684元。基金经理是陶星言和胡超。 基金管理人在中期报告中表示，展望下半年，我们认为港股持续受益于三大利好因素；一、代表新质生产力的科创型公司在港股密集递表，其中有二次上市 的 A 股细分龙头企业，也有中概回归的优质公司。港股市场资产质量不断提升；二、今年以来南下资金不断流入，持续增量资金的流入给市场注入流动性 的同时带来了整体估值水平的提升和优质标的价值发现机会；三、我们认为港股优质标的占比不断提升、 ...

Group 1 - The core viewpoint of the article highlights the performance and management details of the Western Gain Fund's Hong Kong Stock Connect New Opportunities Mixed A Fund, which has shown a net asset increase of 2.83% as of June 30, 2025 [1] - The fund manager, Tao Xingyan, has a strong background in quantitative finance and has held various positions in investment management prior to joining Western Gain Fund in 2019 [1] - The fund's recent share scale changes indicate a total net asset of 0.18 billion yuan, with a significant net asset change rate of -24.80% over the last period [2] Group 2 - The fund's performance metrics show a 3-month return of 16.63%, a 1-year return of 32.92%, and an overall return since inception of -34.23% [2] - The top ten stock holdings of the fund include major companies such as Tencent Holdings, Hong Kong Exchanges, and Alibaba, with a combined holding percentage of 39.68% [2] - Western Gain Fund Management Company, established in July 2010, is based in Shanghai and primarily engages in capital market services, with a registered capital of 370 million yuan [2]

Core Viewpoint - The AI Fund Western Li De Hong Kong Stock Connect New Opportunities Mixed A (008861) reported a profit of 53.96 thousand yuan for Q2 2025, with a weighted average profit per fund share of 0.0189 yuan, and a net asset value growth rate of 3.14% during the period [2]. Fund Performance - As of July 17, the fund's unit net value was 0.658 yuan [2]. - The fund's scale reached 17.6493 million yuan as of the end of Q2 2025 [13]. - The fund's performance over various periods includes: - 3-month net value growth rate: 16.63%, ranking 129 out of 880 comparable funds [2]. - 6-month net value growth rate: 31.25%, ranking 22 out of 880 comparable funds [2]. - 1-year net value growth rate: 32.92%, ranking 124 out of 880 comparable funds [2]. - 3-year net value growth rate: -17.98%, ranking 575 out of 870 comparable funds [2]. Investment Strategy - The fund manager indicated a strategy of gradually realizing gains from technology, new energy vehicles, and consumer companies with reasonable valuations, while increasing positions in innovative pharmaceuticals with favorable policies and potential catalysts [2]. - The fund adopted a barbell strategy in the absence of a clear market direction, enhancing allocation to stable high-dividend assets [2]. Risk Metrics - The fund's 3-year Sharpe ratio was -0.0515, ranking 533 out of 874 comparable funds [7]. - The maximum drawdown over the past three years was 50.65%, ranking 97 out of 864 comparable funds, with the largest single-quarter drawdown occurring in Q1 2022 at 28.84% [9]. Portfolio Composition - The average stock position over the past three years was 81.24%, slightly above the comparable average of 80.33% [12]. - The fund's top ten holdings as of Q2 2025 included Tencent Holdings, Hong Kong Exchanges and Clearing, Alibaba-W, Kingdee International, China Mobile, HSBC Holdings, Xpeng Inc.-W, 3SBio, AIA Group, and BeiGene [16].

通过所选区间该基金净值增长率分位图，可以观察该基金与同类基金业绩比较情况。图为坐标原点到区间内某时点的净值增长率在同类基金中的分位数。 截至3月31日，基金近三年夏普比率为0.0659，位于同类可比基金36/100。 AI基金西部利得港股通新机遇混合A（008861）披露2025年一季报，第一季度基金利润235.06万元，加权平均基金份额本期利润0.0805元。报告期内，基金 净值增长率为15.3%，截至一季度末，基金规模为1716.36万元。 该基金属于灵活配置型基金，长期投资于医药医疗股票。截至4月18日，单位净值为0.564元。基金经理是陶星言和胡超。 基金管理人在一季报中表示，年初以来港股先抑后扬，春节后在国内科技创新带动下港股科技龙头迎来价值重估行情。我们认为目前市场预期风险收益率在 本轮行情中有一定程度收敛，期间我们获利了结了部分达到预期收益的科技成长方向仓位，同时对顺周期板块和医药提升了配置仓位。 截至4月18日，西部利得港股通新机遇混合A近三个月复权单位净值增长率为12.49%，位于同类可比基金52/129；近半年复权单位净值增长率为-4.20%，位于 同类可比基金99/129；近一年复权单位 ...